tiprankstipranks
Trending News
More News >
Moderna (MRNA)
NASDAQ:MRNA
US Market
Advertisement

Moderna (MRNA) Technical Analysis

Compare
17,694 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Moderna’s (MRNA) Moving Averages Convergence Divergence (MACD) indicator is 0.31, suggesting Moderna is a Buy.
Moderna’s (MRNA) 20-Day exponential moving average is 26.79, while Moderna’s (MRNA) share price is $27.49, making it a Buy.
Moderna’s (MRNA) 50-Day exponential moving average is 26.73, while Moderna’s (MRNA) share price is $27.49, making it a Buy.

Moderna (MRNA) Pivot Points

Oct 23, 2025, 02:00 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
24.65
25.52
26.38
27.25
28.11
28.98
29.84
Fibonacci
25.52
26.18
26.59
27.25
27.91
28.32
28.98
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Moderna (MRNA) Moving Averages

Oct 23, 2025, 02:00 AM
Period
Simple
Exponential
MA5
27.12Buy
27.11Buy
MA10
27.09Buy
27.04Buy
MA20
26.82Buy
26.79Buy
MA50
26.01Buy
26.73Buy
MA100
27.60Sell
27.67Sell
MA200
29.58Sell
30.97Sell
Moderna’s (MRNA) 10-Day exponential moving average is 27.04, while Moderna’s (MRNA) share price is $27.49, making it a Buy.
Moderna’s (MRNA) 100-Day exponential moving average is 27.67, while Moderna’s (MRNA) share price is $27.49, making it a Sell.
Moderna’s (MRNA) stock price is $27.49 and Moderna’s (MRNA) 50-day simple moving average is 26.01, creating a Buy signal.
Moderna’s (MRNA) stock price is $27.49 and Moderna’s (MRNA) 100-day simple moving average is 27.60, creating a Sell signal.
Moderna’s (MRNA) stock price is $27.49 and Moderna’s (MRNA) 200-day simple moving average is 29.58, creating a Sell signal.

Moderna (MRNA) Technical Indicators

Oct 23, 2025, 02:00 AM
Name
Value
Implied Action
RSI (14)
54.56
Neutral
STOCH (9,6)
38.17
Neutral
STOCHRSI (14)
39.63
Neutral
MACD (12,26)
0.31
Buy
ADX (14)
18.30
Buy
Williams %R
-52.06
Buy
CCI (14)
28.03
Neutral
ATR (14)
1.38
-
Ultimate Oscillator
43.96
Neutral
ROC
-0.40
Sell
Moderna’s (MRNA) Relative Strength Index (RSI) is 54.56, creating a Neutral signal.
Moderna’s (MRNA) Trend Strength Indicator (ADX) is 18.30, creating a Buy signal.
Moderna’s (MRNA) Commodity Channel Index (CCI) is 28.03, creating a Neutral signal.
Moderna’s (MRNA) Price Rate of Change (ROC) is -0.40, creating a Sell signal.

FAQ

Is MRNA a Buy, Hold, or Sell?
Based on MRNA’s technical indicators, MRNA is a Buy.
    What is MRNA’s RSI (14)?
    MRNA’s RSI (14) is 54.56, which suggests MRNA is a Neutral.
      What is MRNA’s MACD?
      MRNA’s MACD is 0.31, which suggests MRNA is a Buy.
        What is MRNA’s 5-day moving average?
        MRNA’s 5-day moving average is 27.12, which suggests MRNA is a Buy.
          What is MRNA’s 20-day moving average?
          MRNA 20-day moving average is 26.82, which suggests MRNA is a Buy.
            What is MRNA’s 50-day moving average?
            MRNA’s 50-day moving average is 26.01, which suggests MRNA is a Buy.
              What is MRNA’s 200-day moving average?
              MRNA’s 200-day moving average is 29.58, which suggests MRNA is a Sell.
                What is MRNA’s Williams % R (14)?
                MRNA’s Williams % R (14) is -52.06, which suggests MRNA is a Buy.
                  What is MRNA’s CCI (14)?
                  MRNA’s CCI (14) is 28.03, which suggests MRNA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis